ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...
BioAnalysis launches BASIS 2.0, its next-gen GMP-compliant AUC software for gene therapy. Higher throughput, one-click ...
The exported NPX-5 product will now be used in Psyence BioMed’s ongoing Phase IIb clinical trial in Australia – a double-blind, randomized, low-dose comparator-controlled, multi-center study ...
Loti Labs Pioneers Quality in GHRP-6 Research Tampa, United States - March 1, 2026 / Loti Labs / Loti Labs, a prominent ...
The Kisspeptin 10 supplement, an essential research peptide utilized in reproductive endocrinology and neuroendocrine ...
Loti Labs produces GHRP-6 peptides to research-grade specifications, ensuring they meet the exact composition required for controlled and repeatable experimental outcomes. Each batch is meticulously ...
Loti Labs Provides High-Purity Kisspeptin 10 Supplement, Advancing Precision and Quality in Peptide Research ...
Gabriel Gomes believes the future of chemistry is as much about flasks and fume hoods as it is about code. A chemical engineer at Carnegie Mellon University, Gomes works at the intersection of ...
A massive, modern new studio is headed to New Jersey. Alan Mruvka, a real estate developer and the co-creator of E! Entertainment Television, announced today the launch of Filmology Labs: Content ...
The MarketWatch News Department was not involved in the creation of this content. Facility-closure sale of equipment from SoCal-based GenVivo opens on Feb. 11. PASADENA, Calif., Feb. 9, 2026 ...
Facility-closure sale of equipment from SoCal-based GenVivo opens on Feb. 11. PASADENA, Calif., Feb. 9, 2026 /PRNewswire/ -- Bidding opens on February 11 in a major Tiger Group biopharma-industry ...
DALLAS — Texas Instruments is spending $7.5 billion to buy Austin-based tech firm Silicon Labs to extend its chips enterprise. The two companies on Wednesday announced a definitive acquisition ...